Science Market Update

UCSF: New MS Therapy Coming Soon Thanks to NIH & Foundation Research Funding

Posted by Rebecca Inch-Partridge on Mon, Oct 30, 2017

Scientists at UC San Francisco recently published the results of their Phase II Clinical Trial, which showed that an antihistamine restores nervous system function in patients with chronic multiple sclerosis (MS). In this landmark study, the antihistamine, clemastine fumarate, is the first medication that has been shown to reliably restore any brain function damaged by a neurological disease in human patients.

Read More

Tags: University of California San Francisco, Multiple Sclerosis, sell lab products, clinical trials, SFVS, UCSF, laboratory equipment suppliers, Lab Product Sales, UC San Francisco Parnassus, UCSF Mission Bay, BioResearch Product Faire, new scince buildings

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News